Published in
American Medical Association, JAMA Oncology
DOI: 10.1001/jamaoncol.2019.4782
Links
Tools
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
Journal article published in 2020 by
George W. Sledge,
Masakazu Toi,
Patrick Neven,
Joohyuk Sohn,
Kenichi Inoue,
Xavier Pivot,
Olga Burdaeva,
Meena Okera,
Norikazu Masuda,
Peter A. Kaufman,
Han Koh,
Eva-Maria Grischke,
PierFranco Conte 
,
Yi Lu,
Susana Barriga
and other authors.
,
Yi Lu,
Susana Barriga
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 